[Comparison of the results of quantitative polymerase chain reaction for cytomegalovirus among laboratories].

Takehiko Mori, Jun Kato, Akiko Yamane, Yoshinobu Aisa, Tomonori Nakazato, Shinichiro Okamoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

While cytomegalovirus (CMV) antigenemia assay is generally used for the monitoring of CMV reactivation/diseases, plasma real-time polymerase chain reaction (PCR) can also be a promising methodology and it can be performed by commercially available laboratories. In this study, the results of plasma real-time PCR performed by three laboratories were compared with those of CMV antigenemia. In CMV antigenemia-positive patients (N=11), the results of PCR were positive in all cases examined by two laboratories, while one laboratory yielded positive results only in 6 patients. One of the 2 CMV antigenemia-negative patients yielded positive PCR results at two laboratories, but one laboratory did not show positive results. A per-sample analysis showed that, of 84 CMV antigenemia-negative samples, PCR yielded negative results in 44 samples, positive results in 11 samples at three laboratories and at one or two laboratories in the remaining samples. Of the 36 CMV antigenemia-positive samples, PCR yielded positive results in 21 samples at three laboratories and positive results in the remaining samples at one or two laboratories. Although copy number of CMV-DNA evaluated by PCR at 3 laboratories showed a significant correlation with CMV antigenemia values, median copy number of CMV-DNA showed significant differences among the laboratories. Based on these findings, it is suggested that plasma real-time PCR has a higher sensitivity than CMV antigenemia in detecting CMV reactivation. However, the results varied significantly among the laboratories, suggesting that standardization of the methods is warranted.

Original languageEnglish
Pages (from-to)204-209
Number of pages6
Journal[Rinshō ketsueki] The Japanese journal of clinical hematology
Volume52
Issue number4
Publication statusPublished - 2011 Apr

Fingerprint

Cytomegalovirus
Polymerase Chain Reaction
Real-Time Polymerase Chain Reaction
DNA-Directed DNA Polymerase

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Comparison of the results of quantitative polymerase chain reaction for cytomegalovirus among laboratories]. / Mori, Takehiko; Kato, Jun; Yamane, Akiko; Aisa, Yoshinobu; Nakazato, Tomonori; Okamoto, Shinichiro.

In: [Rinshō ketsueki] The Japanese journal of clinical hematology, Vol. 52, No. 4, 04.2011, p. 204-209.

Research output: Contribution to journalArticle

@article{852372e747594ae493fea3215c52b36d,
title = "[Comparison of the results of quantitative polymerase chain reaction for cytomegalovirus among laboratories].",
abstract = "While cytomegalovirus (CMV) antigenemia assay is generally used for the monitoring of CMV reactivation/diseases, plasma real-time polymerase chain reaction (PCR) can also be a promising methodology and it can be performed by commercially available laboratories. In this study, the results of plasma real-time PCR performed by three laboratories were compared with those of CMV antigenemia. In CMV antigenemia-positive patients (N=11), the results of PCR were positive in all cases examined by two laboratories, while one laboratory yielded positive results only in 6 patients. One of the 2 CMV antigenemia-negative patients yielded positive PCR results at two laboratories, but one laboratory did not show positive results. A per-sample analysis showed that, of 84 CMV antigenemia-negative samples, PCR yielded negative results in 44 samples, positive results in 11 samples at three laboratories and at one or two laboratories in the remaining samples. Of the 36 CMV antigenemia-positive samples, PCR yielded positive results in 21 samples at three laboratories and positive results in the remaining samples at one or two laboratories. Although copy number of CMV-DNA evaluated by PCR at 3 laboratories showed a significant correlation with CMV antigenemia values, median copy number of CMV-DNA showed significant differences among the laboratories. Based on these findings, it is suggested that plasma real-time PCR has a higher sensitivity than CMV antigenemia in detecting CMV reactivation. However, the results varied significantly among the laboratories, suggesting that standardization of the methods is warranted.",
author = "Takehiko Mori and Jun Kato and Akiko Yamane and Yoshinobu Aisa and Tomonori Nakazato and Shinichiro Okamoto",
year = "2011",
month = "4",
language = "English",
volume = "52",
pages = "204--209",
journal = "[Rinshō ketsueki] The Japanese journal of clinical hematology",
issn = "0485-1439",
publisher = "Nihon Rinsho Ketsueki Gakkai/Japan Society of Clinical Hematology",
number = "4",

}

TY - JOUR

T1 - [Comparison of the results of quantitative polymerase chain reaction for cytomegalovirus among laboratories].

AU - Mori, Takehiko

AU - Kato, Jun

AU - Yamane, Akiko

AU - Aisa, Yoshinobu

AU - Nakazato, Tomonori

AU - Okamoto, Shinichiro

PY - 2011/4

Y1 - 2011/4

N2 - While cytomegalovirus (CMV) antigenemia assay is generally used for the monitoring of CMV reactivation/diseases, plasma real-time polymerase chain reaction (PCR) can also be a promising methodology and it can be performed by commercially available laboratories. In this study, the results of plasma real-time PCR performed by three laboratories were compared with those of CMV antigenemia. In CMV antigenemia-positive patients (N=11), the results of PCR were positive in all cases examined by two laboratories, while one laboratory yielded positive results only in 6 patients. One of the 2 CMV antigenemia-negative patients yielded positive PCR results at two laboratories, but one laboratory did not show positive results. A per-sample analysis showed that, of 84 CMV antigenemia-negative samples, PCR yielded negative results in 44 samples, positive results in 11 samples at three laboratories and at one or two laboratories in the remaining samples. Of the 36 CMV antigenemia-positive samples, PCR yielded positive results in 21 samples at three laboratories and positive results in the remaining samples at one or two laboratories. Although copy number of CMV-DNA evaluated by PCR at 3 laboratories showed a significant correlation with CMV antigenemia values, median copy number of CMV-DNA showed significant differences among the laboratories. Based on these findings, it is suggested that plasma real-time PCR has a higher sensitivity than CMV antigenemia in detecting CMV reactivation. However, the results varied significantly among the laboratories, suggesting that standardization of the methods is warranted.

AB - While cytomegalovirus (CMV) antigenemia assay is generally used for the monitoring of CMV reactivation/diseases, plasma real-time polymerase chain reaction (PCR) can also be a promising methodology and it can be performed by commercially available laboratories. In this study, the results of plasma real-time PCR performed by three laboratories were compared with those of CMV antigenemia. In CMV antigenemia-positive patients (N=11), the results of PCR were positive in all cases examined by two laboratories, while one laboratory yielded positive results only in 6 patients. One of the 2 CMV antigenemia-negative patients yielded positive PCR results at two laboratories, but one laboratory did not show positive results. A per-sample analysis showed that, of 84 CMV antigenemia-negative samples, PCR yielded negative results in 44 samples, positive results in 11 samples at three laboratories and at one or two laboratories in the remaining samples. Of the 36 CMV antigenemia-positive samples, PCR yielded positive results in 21 samples at three laboratories and positive results in the remaining samples at one or two laboratories. Although copy number of CMV-DNA evaluated by PCR at 3 laboratories showed a significant correlation with CMV antigenemia values, median copy number of CMV-DNA showed significant differences among the laboratories. Based on these findings, it is suggested that plasma real-time PCR has a higher sensitivity than CMV antigenemia in detecting CMV reactivation. However, the results varied significantly among the laboratories, suggesting that standardization of the methods is warranted.

UR - http://www.scopus.com/inward/record.url?scp=79960041597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960041597&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 204

EP - 209

JO - [Rinshō ketsueki] The Japanese journal of clinical hematology

JF - [Rinshō ketsueki] The Japanese journal of clinical hematology

SN - 0485-1439

IS - 4

ER -